<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present report concerns a young woman with long-standing <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et disease (BD), who developed <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> and myasthaenia gravis (MG)-like syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>Although an <z:e sem="disease" ids="C0033774" disease_type="Disease or Syndrome" abbrv="">itching</z:e> sensation after intravenous <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> made treatment more difficult, low-dose oral <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, thalidomide and <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> A relieved the <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0002500'>granulomatous inflammation</z:mp> and pyridostigmine controlled the <z:hpo ids='HP_0000508'>ptosis</z:hpo> </plain></SENT>
</text></document>